GSK (GSK) AIQ Analysis
GSK AIQ Score is 59/100 for investment merit, while Smart Score is 9/10 for peer-relative ranking, with Sharpe -0.33.
Last updated: Jul 25, 2026, 12:00 AM UTC
AIQ Brief
GSK is currently in a mixed setup with AIQ 59/100 and Smart 9/10 (strong relative) at $51.35. Risk is moderate. Read this as a prioritization signal, then confirm entry quality and sizing with your own risk plan.
Quality is the strongest contributor at 81/100, while Momentum is the binding constraint at 33/100. With a 48-point spread, the profile is imbalanced, so patience and entry discipline are more important than speed.
GSK ranks 1/4 in this peer set (59 vs peer average 55.0). On risk-adjusted efficiency, Sharpe is above peer average (-0.33 vs -1.21). This helps distinguish true relative leadership from broad sector drift.
Action now: this is a neutral/selective setup. Improve entry quality by waiting for momentum acceleration or a better risk profile before adding. Keep sizing moderate until factors align.
Sharpe is -0.33, which is negative: recent return has not compensated for risk over this lookback window.
| AIQ Component | Score | Signal Read |
|---|---|---|
| Momentum | 33 | Weak momentum profile and lower trend persistence. |
| Value | 66 | Valuation appears close to fair value. |
| Quality | 81 | Profitability and consistency profile is strong. |
| Risk | 47 | Risk profile is moderate and manageable. |
| Sentiment | — | Sentiment signal is currently unavailable. |
Current AIQ Read
GSK currently screens as neutral. Wait for confirmation from trend quality and risk conditions before increasing exposure.
Loading GSK analysis...